NCT03949452

Brief Summary

The investegators aimed to compare the efficacy of subcostal Transversus abdominis plane analgesia, to epidural analgesia intra and postoperatively in upper abdominal surgeries.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 8, 2019

Completed
2 days until next milestone

Study Start

First participant enrolled

May 10, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 14, 2019

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2020

Completed
Last Updated

September 11, 2020

Status Verified

May 1, 2019

Enrollment Period

6 months

First QC Date

May 8, 2019

Last Update Submit

September 9, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Total morphine consumption

    Intravenous morphine in adose of 0.05 mg/kg will be given if Visual Analogue Scale (VAS) is more than 30 mm in both groups and can be repeated every 15 minutes till Visual Analogue Scale become less than 3. Morphine administration will be ceased when the Visual Analogue Scale score \<30 mm on assessment or when over-sedation or respiratory depression occurred (a respiratory rate of \< 10 bpm). Doses given will be calculated daily and recorded.

    For 72 hours after surgery

Secondary Outcomes (10)

  • First request for rescue analgesia

    for 72 hours after surgery

  • Pain Scores

    up to 72 hours postoperatively

  • Heart rate

    for 72 hours postoperative

  • Mean arterial blood pressure

    for 72 hours postoperative

  • Peripheral oxygen saturation

    for 72 hours postoperative

  • +5 more secondary outcomes

Study Arms (2)

Subcostal Transversus Abdominis Plane catheter

ACTIVE COMPARATOR

This group includes patients who will receive subcostal Transversus abdominis plane block analgesia

Other: Subcostal Transversus Abdominis Plane catheter

Epidural catheter

PLACEBO COMPARATOR

This group includes patients who will receive epidural analgesia using a catheter technique

Other: Epidural catheter

Interventions

Prior to surgery, an ultrasound guided unilateral Subcostal Transversus abdominis plane bolus dose (consisting of amixture of 10 ml bupivaccaine 0.5% plus 100 mg magnesium sulphate to be completed by normal saline to a total volume of 20 ml mixture) will be given on the same side of the surgical incision. At the end of surgery, A Transversus abdominis plane catheter will be inserted unilaterally by surgeon during wound closure. Then postoperatively, Transversus abdominis plane infusion of a solution mixture prepared in multiple 50 cm syringes each syringe contain 20 ml bupivacaine 0.5% plus 100 mg magnesium sulphate to be balanced by normal saline to 50 ml solution mixture ( final concentration of bupivacaine is 0.2%). This solution mixture will be infused through Transversus abdominis plane catheter at a rate of 6 ml/hour for 72 hours postoperatively.

Subcostal Transversus Abdominis Plane catheter

Prior to surgery, we will site an epidural catheter in the thoracic T7-T9 region, and inject an epidural bolus dose same as described above (consisting of amixture of 10 ml bupivaccaine 0.5% plus 100 mg magnesium sulphate to be completed by normal saline to a total volume of 20 ml mixture) for intra operative analgesia. Postoperatively, patients will receive epidural infusion of the solution mixture (same as described above) prepared in multiple 50 cm syringes each syringe contain 20 ml bupivaccaine 0.5% plus 100 mg magnesium sulphate to be balanced by normal saline to 50 ml solution mixture ( final concentration of bupivaccaine is 0.2%). This solution mixture will be infused epidurally at a rate of 6 ml/hour for 72 hours (3 days) postoperatively.

Epidural catheter

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • American Society of Anesthesiologists (ASA) physical status I, II or III
  • The incision included is right subcostal incision for major upper abdominal surgeries (partial hepatectomy, pancreatic surgery included Whipple's procedure, total pancreatectomy and distal pancreatectomy) and other operations using the same incision.

You may not qualify if:

  • Patient refusal.
  • Hematological diseases.
  • Bleeding diseases.
  • Coagulation abnormality.
  • Local skin infection
  • Sepsis at site of the block.
  • Known hypersensitivity to the study drugs.
  • Body Mass Index \> 35 Kg/m2.
  • If the lower end of the incision extended below T10 (umbilicus).
  • If the incision extended laterally beyond the anterior axillary line or extended to pass the midline to the other side.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mansoura University

Al Mansurah, DK, 050, Egypt

Location

Related Publications (2)

  • Hebbard P. Subcostal transversus abdominis plane block under ultrasound guidance. Anesth Analg. 2008 Feb;106(2):674-5; author reply 675. doi: 10.1213/ane.0b013e318161a88f. No abstract available.

  • Culebras X, Van Gessel E, Hoffmeyer P, Gamulin Z. Clonidine combined with a long acting local anesthetic does not prolong postoperative analgesia after brachial plexus block but does induce hemodynamic changes. Anesth Analg. 2001 Jan;92(1):199-204. doi: 10.1097/00000539-200101000-00038.

Study Officials

  • Mohamed Y Makharita, MD

    Professor of Anesthesia and Surgical Intensive Care

    STUDY CHAIR
  • Hazem ES Moawad, MD

    Assistant Professor of Anesthesia and Surgical Intensive Care

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Double blind (participant, investigator) study
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 8, 2019

First Posted

May 14, 2019

Study Start

May 10, 2019

Primary Completion

November 1, 2019

Study Completion

January 1, 2020

Last Updated

September 11, 2020

Record last verified: 2019-05

Data Sharing

IPD Sharing
Will share

De-identified individual participant data for all primary and secondary outcome measures will be made available

Shared Documents
STUDY PROTOCOL
Time Frame
data will be available within 6 monthes of study completion.
Access Criteria
Data may be shared by contacting the principle investegator.

Locations